Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TCR2 THERAPEUTICS INC.

(TCRR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 3421 032197--
Entreprise Value (EV)1 3421 032-48,811749,4
P/E ratio -3,09x-12,9x-1,95x-1,69x-1,48x
Yield -----
Capitalization / Revenue ----83,3x
EV / Revenue ----20,9x
EV / EBITDA -----
Price to Book -----
Nbr of stocks (in thousands) 23 94433 38038 220--
Reference price (USD) 14,330,95,155,155,15
Announcement Date 03/30/202003/11/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 -----2,36
EBITDA ------
Operating profit (EBIT)1 -26,5-51,4-68,7-101-124-148
Operating Margin ------6 276%
Pre-Tax Profit (EBT)1 -61,5-47,5-67,0-100-123-146
Net income1 -61,5-97,5-67,1-100,0-120-141
Net margin ------5 979%
EPS2 -9,50-4,62-2,40-2,65-3,05-3,47
Dividend per Share ------
Announcement Date 03/29/201903/30/202003/11/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -21,6-24,3-26,2-28,7-28,8-29,7
Operating Margin ------
Pre-Tax Profit (EBT)1 -21,5-24,3-26,2-28,1-27,9-28,1
Net income1 -21,5-24,3-26,2-28,1-27,9-28,1
Net margin ------
EPS2 -0,58-0,64-0,69-0,74-0,75-0,73
Dividend per Share ------
Announcement Date 05/13/202108/05/202111/10/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 ---24679,5147
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -19,8-45,2-63,9-90,7-108-129
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 1,023,887,167,057,868,31
Capex / Sales -----352%
Announcement Date 03/29/201903/30/202003/11/2021---
1 USD in Million
Key data
Capitalization (USD) 196 835 286
Number of employees 164
Free-Float 96,4%
Free-Float capitalization (USD) 189 705 121
Avg. Exchange 20 sessions (USD) 3 935 347
Average Daily Capital Traded 2,00%
EPS & Dividend